🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the single dose pharmacokineti...
Status
Completed
Location
PRA Health Sciences 2
Start Date
2021-11-16
Trial ID
NCT05112939
This phase I trial tests the safety and effectiveness of nivolumab and ipil...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-23
Trial ID
NCT07128680
The purpose of the study is to investigate how quickly and to what extent Y...
Status
Completed
Location
Pharma Bio-Research B.V.
Start Date
2005-01
Trial ID
NCT01646294
Treatments Being Tested
Study to Evaluate the safety and efficacy of a Latanoprost/Minoxidil formul...
Status
Unknown
Location
WellMax
Start Date
2023-03-11
Trial ID
NCT05790941
Treatments Being Tested
Researchers are looking for new weight loss medicines for people with highe...
Status
Not Yet Recruiting
Location
ProSciento Inc. ( Site 0002)
Start Date
2026-08-25
Trial ID
NCT07748351
Treatments Being Tested
A Phase 1 study to evaluate safety, tolerability and immunogenicity a RSV v...
Status
Not Yet Recruiting
Location
Emeritus Research Sydney
Start Date
2026-04-01
Trial ID
NCT07492706
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2021-02-24
Trial ID
NCT06181045
This phase III trial compares the combination of four drugs (daratumumab, b...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-02-24
Trial ID
NCT04566328
The purpose of this study is to evaluate the fluoride dose response of diff...
Status
Completed
Location
Indiana University School of Dentistry, Oral Health Research Institute
Start Date
2017-12-19
Trial ID
NCT03383783
This is a Phase 1, randomized, open label, 4-period, 6-sequence, partial cr...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2017-09-11
Trial ID
NCT03112148
Treatments Being Tested